{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:57:33Z","timestamp":1793228253283,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2021\/002419"],"award-info":[{"award-number":["CRG\/2021\/002419"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["ECR\/2017\/000858"],"award-info":[{"award-number":["ECR\/2017\/000858"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018975","name":"Uka Tarsadia University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018975","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.humimm.2023.110737","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T18:47:33Z","timestamp":1701802053000},"page":"110737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Altered regulatory T cell-mediated Natural Killer cells suppression may lead to generalized vitiligo"],"prefix":"10.1016","volume":"85","author":[{"given":"Prashant S.","family":"Giri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1114-1323","authenticated-orcid":false,"given":"Soaeb S.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8497-0765","authenticated-orcid":false,"given":"Mitesh","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2023.110737_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000506103","article-title":"Vitiligo: A Review","volume":"236","author":"Bergqvist","year":"2020","journal-title":"Dermatology"},{"key":"10.1016\/j.humimm.2023.110737_b0010","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000131485","article-title":"Autoimmune etiology of generalized vitiligo","volume":"10","author":"Le Poole","year":"2008","journal-title":"Curr. Dir. Autoimmun."},{"key":"10.1016\/j.humimm.2023.110737_b0015","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/exd.12372","article-title":"Role of oxidative stress and autoimmunity in onset and progression of vitiligo","volume":"23","author":"Laddha","year":"2014","journal-title":"Exp Dermatol."},{"key":"10.1016\/j.humimm.2023.110737_b0020","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/pcmr.12105","article-title":"Decreased regulatory T-cells and CD4(+) \/CD8(+) ratio correlate with disease onset and progression in patients with generalized vitiligo","volume":"26","author":"Dwivedi","year":"2013","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.humimm.2023.110737_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.145295","article-title":"Dwivedi, Association of FOXP3 and GAGE10 promoter polymorphisms and decreased FOXP3 expression in regulatory T cells with susceptibility to generalized vitiligo in Gujarat population","volume":"768","author":"Giri","year":"2021","journal-title":"Gene"},{"key":"10.1016\/j.humimm.2023.110737_b0030","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1365-2133.2012.11000.x","article-title":"Interleukin-4 genetic variants correlate with its transcript and protein levels in patients with vitiligo","volume":"167","author":"Imran","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.humimm.2023.110737_b0035","doi-asserted-by":"crossref","first-page":"e107020","DOI":"10.1371\/journal.pone.0107020","article-title":"Association of neuropeptide Y (NPY), interleukin-1B (IL1B) genetic variants and correlation of IL1B transcript levels with vitiligo susceptibility","volume":"9","author":"Laddha","year":"2014","journal-title":"PLoS One."},{"key":"10.1016\/j.humimm.2023.110737_b0040","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/bjd.12467","article-title":"Association of NLRP1 genetic variants and mRNA overexpression with generalized vitiligo and disease activity in a Gujarat population","volume":"169","author":"Dwivedi","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.humimm.2023.110737_b0045","doi-asserted-by":"crossref","first-page":"e0180958","DOI":"10.1371\/journal.pone.0180958","article-title":"A case-control study on association of proteasome subunit beta 8 (PSMB8) and transporter associated with antigen processing 1 (TAP1) polymorphisms and their transcript levels in vitiligo from Gujarat","volume":"12","author":"Jadeja","year":"2017","journal-title":"PLoS One."},{"key":"10.1016\/j.humimm.2023.110737_b0050","doi-asserted-by":"crossref","DOI":"10.1111\/pcmr.13101","article-title":"Trained immunity in the pathogenesis of vitiligo","author":"Post","year":"2023","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.humimm.2023.110737_b0055","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ni1582","article-title":"Functions of natural killer cells","volume":"9","author":"Vivier","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.humimm.2023.110737_b0060","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0190-9622(86)70085-6","article-title":"Aberrations in T lymphocytes and natural killer cells in vitiligo: A flow cytometric study","volume":"14","author":"Halder","year":"1986","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.humimm.2023.110737_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.613056","article-title":"Targeting innate immunity to combat cutaneous stress: the vitiligo perspective","volume":"12","author":"Boniface","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2023.110737_b0070","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/j.1468-3083.2008.02681.x","article-title":"Evaluation of activatory and inhibitory natural killer cell receptors in non-segmental vitiligo: a flow cytometric study","volume":"22","author":"Basak","year":"2008","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.humimm.2023.110737_b0075","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0190-9622(89)70069-4","article-title":"Circadian rhythm of natural killer cell activity in vitiligo","volume":"20","author":"Mozzanica","year":"1989","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.humimm.2023.110737_b0080","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/s41467-019-09963-8","article-title":"Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo","volume":"10","author":"Tulic","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.humimm.2023.110737_b0085","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1089\/jir.2012.0171","article-title":"Involvement of interferon-gamma genetic variants and intercellular adhesion molecule-1 in onset and progression of generalized Vitiligo","volume":"33","author":"Dwivedi","year":"2013","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.humimm.2023.110737_b0090","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-3083.2009.02308.x","article-title":"How do regulatory T cells work?","volume":"70","author":"Corthay","year":"2009","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.humimm.2023.110737_b0095","doi-asserted-by":"crossref","first-page":"6952299","DOI":"10.1155\/2022\/6952299","article-title":"Meta-analysis of alterations in regulatory T cells\u2019 frequency and suppressive capacity in patients with vitiligo","volume":"2022","author":"Giri","year":"2022","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.humimm.2023.110737_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037513","article-title":"Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo","volume":"7","author":"Lili","year":"2012","journal-title":"PLoS One."},{"key":"10.1016\/j.humimm.2023.110737_b0105","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/bjd.13511","article-title":"Alteration in regulatory T cells and programmed cell death 1-expressing regulatory T cells in active generalized vitiligo and their clinical correlation","volume":"172","author":"Tembhre","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.humimm.2023.110737_b0110","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/imm.13538","article-title":"Calcium controlled NFATc1 activation enhances suppressive capacity of regulatory T cells isolated from generalized vitiligo patients","volume":"167","author":"Giri","year":"2022","journal-title":"Immunology."},{"key":"10.1016\/j.humimm.2023.110737_b0115","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/exd.14157","article-title":"Decreased suppression of CD8+ and CD4+ T cells by peripheral regulatory T cells in generalized vitiligo due to reduced NFATC1 and FOXP3 proteins","volume":"29","author":"Giri","year":"2020","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.humimm.2023.110737_b0120","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4103\/0378-6323.26722","article-title":"Scoring systems in dermatology","volume":"72","author":"Bhor","year":"2006","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"10.1016\/j.humimm.2023.110737_b0125","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.humimm.2017.02.006","article-title":"Impaired NK cell functionality and increased TNF-\u03b1 production as biomarkers of chronic chikungunya arthritis and rheumatoid arthritis","volume":"78","author":"Thanapati","year":"2017","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2023.110737_b0130","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-0560.1984.tb00361.x","article-title":"Immunopathology of vitiligo vulgaris, Sutton\u2019s leukoderma and melanoma-associated vitiligo in relation to steroid effects: II The IgG and C3 deposits in the skin","volume":"11","author":"Uda","year":"1984","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/j.humimm.2023.110737_b0135","doi-asserted-by":"crossref","DOI":"10.3791\/56191","article-title":"A flow cytometry-based cytotoxicity assay for the assessment of human NK cell activity","author":"Kandarian","year":"2017","journal-title":"J. vis. Exp."},{"key":"10.1016\/j.humimm.2023.110737_b0140","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/j.bbmt.2009.10.009","article-title":"Natural killer cells: tolerance to self and innate immunity to viral infection and malignancy","volume":"16","author":"Yokoyama","year":"2010","journal-title":"Biol. Blood Marrow Transplant. J. Am. Soc. Blood Marrow Transplant."},{"key":"10.1016\/j.humimm.2023.110737_b0145","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12865-018-0272-x","article-title":"Expression of ligands for activating natural killer cell receptors on cell lines commonly used to assess natural killer cell function","volume":"20","author":"Tremblay-McLean","year":"2019","journal-title":"BMC Immunol."},{"key":"10.1016\/j.humimm.2023.110737_b0150","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/cmi.2013.2","article-title":"Interaction between natural killer cells and regulatory T cells: perspectives for immunotherapy","volume":"10","author":"Pedroza-Pacheco","year":"2013","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.humimm.2023.110737_b0155","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1002\/eji.200838813","article-title":"NK cells and Treg cells: A fascinating dance cheek to cheek","volume":"38","author":"Zimmer","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.humimm.2023.110737_b0160","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12977-015-0191-3","article-title":"Activated regulatory T cells suppress effector NK cell responses by an IL-2-mediated mechanism during an acute retroviral infection","volume":"12","author":"Littwitz-Salomon","year":"2015","journal-title":"Retrovirology."},{"key":"10.1016\/j.humimm.2023.110737_b0165","first-page":"417","article-title":"The Role of NKG2D in Vitiligo","volume":"12","author":"Plaza-Rojas","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2023.110737_b0170","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/08820139.2013.773337","article-title":"Measurement of suppressor activity of T CD4+CD25+ T reg cells using bromodeoxyuridine incorporation assay","volume":"42","author":"Avalos-Mart\u00ednez","year":"2013","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.humimm.2023.110737_b0175","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.autrev.2014.10.002","article-title":"Regulatory T cells in vitiligo: Implications for pathogenesis and therapeutics","volume":"14","author":"Dwivedi","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.humimm.2023.110737_b0180","doi-asserted-by":"crossref","first-page":"e51040","DOI":"10.1371\/journal.pone.0051040","article-title":"Transcriptome analysis reveals markers of aberrantly activated innate immunity in vitiligo lesional and non-lesional skin","volume":"7","author":"Yu","year":"2012","journal-title":"PLoS One."},{"key":"10.1016\/j.humimm.2023.110737_b0185","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.immuni.2016.05.008","article-title":"Inflammasome-dependent induction of adaptive NK cell memory","volume":"44","author":"van den Boorn","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.humimm.2023.110737_b0190","doi-asserted-by":"crossref","unstructured":"M. Grau, S. Valsesia, J. Mafille, S. Djebali, M. Tomkowiak, A.-L. Mathieu, D. Laubreton, S. de Bernard, P.-E. Jouve, E. Ventre, L. Buffat, T. Walzer, Y. Leverrier, J. Marvel, Antigen-Induced but Not Innate Memory CD8 T Cells Express NKG2D and Are Recruited to the Lung Parenchyma upon Viral Infection, J. Immunol. 200 (2018) 3635 LP \u2013 3646. Doi: 10.4049\/jimmunol.1701698.","DOI":"10.4049\/jimmunol.1701698"},{"key":"10.1016\/j.humimm.2023.110737_b0195","article-title":"NK Cells in Autoimmune Diseases: Protective or Pathogenic?","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2023.110737_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102417","article-title":"Innate inflammation drives NK cell activation to impair Treg activity","volume":"108","author":"Dean","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.humimm.2023.110737_b0205","doi-asserted-by":"crossref","unstructured":"K.S. Friedmann, A. Kn\u00f6rck, S. Cappello, C. Hoxha, G. Schw\u00e4r, S. Iden, I. Bogeski, C. Kummerow, E.C. Schwarz, M. Hoth, Combined CTL and NK cell cytotoxicity against cancer cells, BioRxiv. (2020) 2020.06.14.150672. Doi: 10.1101\/2020.06.14.150672.","DOI":"10.1101\/2020.06.14.150672"},{"key":"10.1016\/j.humimm.2023.110737_b0210","first-page":"1","article-title":"Tumor necrosis factor a promotor polymorphism and nonsegmental vitiligo : a molecular susceptibility marker in Egyptian women","volume":"3","author":"Laddha","year":"2012","journal-title":"PLoS One."},{"key":"10.1016\/j.humimm.2023.110737_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155432","article-title":"Tumor Necrosis Factor-alpha affects melanocyte survival and melanin synthesis via multiple pathways in vitiligo","volume":"140","author":"Singh","year":"2021","journal-title":"Cytokine."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885923003713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885923003713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:59:15Z","timestamp":1759319955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885923003713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0198885923003713"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2023.110737","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered regulatory T cell-mediated Natural Killer cells suppression may lead to generalized vitiligo","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2023.110737","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110737"}}